Literature DB >> 15572665

Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes.

Amir Sonnenblick1, Carmit Levy, Ehud Razin.   

Abstract

Microphthalmia transcription factor (MITF) and STAT3 are two transcription factors that play a major role in the regulation of growth and function in mast cells and melanocytes. In the present study, we explored the MITF-PIAS3-STAT3 network of interactions, how these interactions regulate gene expression, and how cytokine-mediated phosphorylation of MITF and STAT3 is involved in the in vivo interplay between these three proteins. In NIH 3T3 cells stimulated via gp130 receptor, transfected MITF was found to be phosphorylated at S409. Such phosphorylation of MITF leads to PIAS3 dissociation from MITF and its association with STAT3. Activation of mouse melanoma and mast cells through gp130 or c-Kit receptors induced the mobilization of PIAS3 from MITF to STAT3. In mast cells derived from MITF(di/di) mice, whose MITF lacks the Zip domain (PIAS3-binding domain), we found downregulation in mRNA levels of genes regulated by either MITF or STAT3. This regulatory mechanism is of considerable importance since it is likely to advance the deciphering of a role for MITF and STAT3 in mast cells and melanocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15572665      PMCID: PMC533964          DOI: 10.1128/MCB.24.24.10584-10592.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance.

Authors:  K Takeda; C Takemoto; I Kobayashi; A Watanabe; Y Nobukuni; D E Fisher; M Tachibana
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

Review 2.  Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.

Authors:  T Hirano; K Ishihara; M Hibi
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

3.  c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi.

Authors:  M Wu; T J Hemesath; C M Takemoto; M A Horstmann; A G Wells; E R Price; D Z Fisher; D E Fisher
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

Review 4.  STATs in oncogenesis.

Authors:  T Bowman; R Garcia; J Turkson; R Jove
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

5.  Genomic, transcriptional and mutational analysis of the mouse microphthalmia locus.

Authors:  J H Hallsson; J Favor; C Hodgkinson; T Glaser; M L Lamoreux; R Magnúsdóttir; G J Gunnarsson; H O Sweet; N G Copeland; N A Jenkins; E Steingrímsson
Journal:  Genetics       Date:  2000-05       Impact factor: 4.562

6.  Suppression of microphthalmia transcriptional activity by its association with protein kinase C-interacting protein 1 in mast cells.

Authors:  E Razin; Z C Zhang; H Nechushtan; S Frenkel; Y N Lee; R Arudchandran; J Rivera
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

7.  Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling.

Authors:  D Sinibaldi; W Wharton; J Turkson; T Bowman; W J Pledger; R Jove
Journal:  Oncogene       Date:  2000-11-16       Impact factor: 9.867

8.  The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3.

Authors:  B Rödel; K Tavassoli; H Karsunky; T Schmidt; M Bachmann; F Schaper; P Heinrich; K Shuai; H P Elsässer; T Möröy
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

9.  Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo.

Authors:  J R Grandis; S D Drenning; Q Zeng; S C Watkins; M F Melhem; S Endo; D E Johnson; L Huang; Y He; J D Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

10.  Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability.

Authors:  Gaël G McGill; Martin Horstmann; Hans R Widlund; Jinyan Du; Gabriela Motyckova; Emi K Nishimura; Yi-Ling Lin; Sridhar Ramaswamy; William Avery; Han-Fei Ding; Siobhán A Jordan; Ian J Jackson; Stanley J Korsmeyer; Todd R Golub; David E Fisher
Journal:  Cell       Date:  2002-06-14       Impact factor: 41.582

View more
  24 in total

Review 1.  Regulation of melanocyte pivotal transcription factor MITF by some other transcription factors.

Authors:  Ping Wan; Yongqing Hu; Li He
Journal:  Mol Cell Biochem       Date:  2011-04-26       Impact factor: 3.396

2.  Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer.

Authors:  Amy Kluge; Snehal Dabir; Jeffrey Kern; David Nethery; Balazs Halmos; Patrick Ma; Afshin Dowlati
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

3.  Retinal pigment epithelium transcriptome analysis in chronic smoking reveals a suppressed innate immune response and activation of differentiation pathways.

Authors:  Lei Wang; Koray D Kaya; Sujung Kim; Matthew J Brooks; Jie Wang; Ying Xin; Jiang Qian; Anand Swaroop; James T Handa
Journal:  Free Radic Biol Med       Date:  2020-07-04       Impact factor: 7.376

4.  Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis.

Authors:  Amir Sonnenblick; Anat Shriki; E Galun; Jonathan H Axelrod; Hagit Daum; Yakir Rottenberg; Tamar Hamburger; Bela Mali; Tamar Peretz
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

5.  Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells.

Authors:  F H Hsieh; P Sharma; A Gibbons; T Goggans; S C Erzurum; S J Haque
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

Review 6.  Pathways from senescence to melanoma: focus on MITF sumoylation.

Authors:  J Leclerc; R Ballotti; C Bertolotto
Journal:  Oncogene       Date:  2017-08-21       Impact factor: 9.867

7.  PIAS1 activates the expression of smooth muscle cell differentiation marker genes by interacting with serum response factor and class I basic helix-loop-helix proteins.

Authors:  Keiko Kawai-Kowase; Meena S Kumar; Mark H Hoofnagle; Tadashi Yoshida; Gary K Owens
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

8.  Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M.

Authors:  Iyoko Katoh; Anna Mírová; Shun-ichi Kurata; Yasushi Murakami; Kenji Horikawa; Natsuko Nakakuki; Takunobu Sakai; Kunihiko Hashimoto; Ayako Maruyama; Takaaki Yonaga; Nahoko Fukunishi; Kohji Moriishi; Hirohisa Hirai
Journal:  Neoplasia       Date:  2011-11       Impact factor: 5.715

9.  PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.

Authors:  Tomohiro Hikata; Hironari Takaishi; Jiro Takito; Akihiro Hakozaki; Mitsuru Furukawa; Shinichi Uchikawa; Tokuhiro Kimura; Yasunori Okada; Masahito Matsumoto; Akihiko Yoshimura; Riko Nishimura; Sakamuri V Reddy; Hiroshi Asahara; Yoshiaki Toyama
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

10.  Thrombopoietin inhibits murine mast cell differentiation.

Authors:  Fabrizio Martelli; Barbara Ghinassi; Rodolfo Lorenzini; Alessandro M Vannucchi; Rosa Alba Rana; Mitsuo Nishikawa; Sandra Partamian; Giovanni Migliaccio; Anna Rita Migliaccio
Journal:  Stem Cells       Date:  2008-02-14       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.